Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verona Pharma PLC
Total Equity Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Total Equity
$130.5m
CAGR 3-Years
-8%
CAGR 5-Years
21%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Total Equity
ÂŁ14.4B
CAGR 3-Years
-2%
CAGR 5-Years
32%
CAGR 10-Years
9%
AstraZeneca PLC
LSE:AZN
Total Equity
$39.5B
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
6%
Indivior PLC
LSE:INDV
Total Equity
-$121m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Equity
$2.3B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
7%
Dechra Pharmaceuticals PLC
LSE:DPH
Total Equity
ÂŁ755.2m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
16%

See Also

What is Verona Pharma PLC's Total Equity?
Total Equity
130.5m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Total Equity amounts to 130.5m USD.

What is Verona Pharma PLC's Total Equity growth rate?
Total Equity CAGR 5Y
21%

Over the last year, the Total Equity growth was -50%. The average annual Total Equity growth rates for Verona Pharma PLC have been -8% over the past three years , 21% over the past five years .

Back to Top